breast cancer gene therapy (ICRF)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namebreast cancer gene therapy (ICRF)
Drug Alias NameGPAT (Imperial Cancer Research Fund)genetic prodrug activation therapy (ICRF)GPAT
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe UK Imperial Cancer Research Fund
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe UK Imperial Cancer Research FundGenzyme Corp
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A